Th22 and related cytokines in inflammatory and autoimmune diseases

Bibliography

• Sinha AA, Lopez MT, McDevitt HO. Autoimmune diseases: the failure of self tolerance. Science 1990;248:1380-8
   PubMed Web of Science ®Google Scholar
• Invernizzi P. Future directions in genetic for autoimmune diseases. J Autoimmun 2009;33:1-2
   Google Scholar
• Ma D, Zhu Y, Ji C, Hou M. Targeting the Notch signaling pathway in autoimmune diseases. Expert Opin Ther Targets 2010;14:553-65
   Web of Science ®Google Scholar
• Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-73
   PubMed Web of Science ®Google Scholar
• Murphy KM, Reiner SL. The lineage decisions of helper T cells. Nat Rev Immunol 2002;2:933-44
   PubMed Web of Science ®Google Scholar
• Annunziato F, Romagnani S. Heterogeneity of human effector CD4+ T cells. Arthritis Res Ther 2009;11:257
   PubMed Web of Science ®Google Scholar
• Schwarzenberger P, Kolls JK. Interleukin 17: an example for gene therapy as a tool to study cytokine mediated regulation of hematopoiesis. J Cell Biochem Suppl 2002;38:88-95
   PubMedGoogle Scholar
• Fouser LA, Wright JF, Dunussi-Joannopoulos K, Collins M. Th17 cytokines and their emerging roles in inflammation and autoimmunity. Immunol Rev 2008;226:87-102
   PubMed Web of Science ®Google Scholar
• Pene J, Chevalier S, Preisser L, Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol 2008;180:7423-30
   PubMed Web of Science ®Google Scholar
• Bettelli E, Korn T, Oukka M, Kuchroo VK. Induction and effector functions of T(H)17 cells. Nature 2008;453:1051-7
   PubMed Web of Science ®Google Scholar
• Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008;28:454-67
   PubMed Web of Science ®Google Scholar
• Duhen T, Geiger R, Jarrossay D, Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 2009;10:857-63
   PubMed Web of Science ®Google Scholar
• Eyerich S, Eyerich K, Pennino D, Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 2009;119:3573-85
   PubMed Web of Science ®Google Scholar
• Trifari S, Kaplan CD, Tran EH, Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol 2009;10:864-71
   PubMed Web of Science ®Google Scholar
• Fujita H, Nograles KE, Kikuchi T, Human langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production. Proc Natl Acad Sci USA 2009;106:21795-800
   PubMed Web of Science ®Google Scholar
• Zhang L, Li YG, Li YH, Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis. PLoS One 2012;7:e31000
   PubMed Web of Science ®Google Scholar
• Blumberg H, Conklin D, Xu WF, Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 2001;104:9-19
   PubMed Web of Science ®Google Scholar
• Langer JA, Cutrone EC, Kotenko S. The Class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions. Cytokine Growth Factor Rev 2004;15:33-48
   PubMed Web of Science ®Google Scholar
• Leipe J, Schramm MA, Grunke M, Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritis. Ann Rheum Dis 2011;70:1453-7
   PubMed Web of Science ®Google Scholar
• Pickert G, Neufert C, Leppkes M, STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med 2009;206:1465-72
   PubMed Web of Science ®Google Scholar
• Wolk K, Witte E, Witte K, Biology of interleukin-22. Semin Immunopathol 2010;32:17-31
   PubMed Web of Science ®Google Scholar
• Dumoutier L, Van Roost E, Ameye G, IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes. Genes Immun 2000;1:488-94
   PubMed Web of Science ®Google Scholar
• Xu T, Logsdon NJ, Walter MR. Structure of insect-cell-derived IL-22. Acta Crystallogr D Biol Crystallogr 2005;61:942-50
   Google Scholar
• Zhang N, Pan HF, Ye DQ. Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention. Mol Cell Biochem 2011;353:41-6
   Web of Science ®Google Scholar
• Nograles KE, Zaba LC, Shemer A, IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol 2009;123:1244-52; e2
   PubMed Web of Science ®Google Scholar
• Zheng Y, Danilenko DM, Valdez P, Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007;445:648-51
   PubMed Web of Science ®Google Scholar
• Cella M, Fuchs A, Vermi W, A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009;457:722-5
   PubMed Web of Science ®Google Scholar
• Zenewicz LA, Yancopoulos GD, Valenzuela DM, Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 2008;29:947-57
   PubMed Web of Science ®Google Scholar
• Zheng Y, Valdez PA, Danilenko DM, Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008;14:282-9
   PubMed Web of Science ®Google Scholar
• Dumoutier L, Van Roost E, Colau D, Renauld JC. Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc Natl Acad Sci USA 2000;97:10144-9
   PubMed Web of Science ®Google Scholar
• Xie MH, Aggarwal S, Ho WH, Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem 2000;275:31335-9
   PubMed Web of Science ®Google Scholar
• Kotenko SV, Izotova LS, Mirochnitchenko OV, Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J Biol Chem 2001;276:2725-32
   PubMed Web of Science ®Google Scholar
• Wolk K, Kunz S, Asadullah K, Sabat R. Cutting edge: immune cells as sources and targets of the IL-10 family members? J Immunol 2002;168:5397-402
   PubMed Web of Science ®Google Scholar
• Wolk K, Sabat R. Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev 2006;17:367-80
   PubMed Web of Science ®Google Scholar
• Wolk K, Witte E, Reineke U, Is there an interaction between interleukin-10 and interleukin-22? Genes Immun 2005;6:8-18
   PubMed Web of Science ®Google Scholar
• Wolk K, Kunz S, Witte E, IL-22 increases the innate immunity of tissues. Immunity 2004;21:241-54
   PubMed Web of Science ®Google Scholar
• Reineke U, Schneider-Mergener J, Glaser RW, Evidence for conformationally different states of interleukin-10: binding of a neutralizing antibody enhances accessibility of a hidden epitope. J Mol Recognit 1999;12:242-8
   PubMedGoogle Scholar
• Eyerich S, Wagener J, Wenzel V, IL-22 and TNF-alpha represent a key cytokine combination for epidermal integrity during infection with Candida albicans. Eur J Immunol 2011;41:1894-901
   PubMed Web of Science ®Google Scholar
• Dumoutier L, Lejeune D, Colau D, Renauld JC. Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22. J Immunol 2001;166:7090-5
   PubMed Web of Science ®Google Scholar
• Kotenko SV, Izotova LS, Mirochnitchenko OV, Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity. J Immunol 2001;166:7096-103
   PubMed Web of Science ®Google Scholar
• Geboes L, Dumoutier L, Kelchtermans H, Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice. Arthritis Rheum 2009;60:390-5
   PubMed Web of Science ®Google Scholar
• Lejeune D, Dumoutier L, Constantinescu S, Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J Biol Chem 2002;277:33676-82
   PubMed Web of Science ®Google Scholar
• Wolk K, Witte E, Hoffmann U, IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn's disease. J Immunol 2007;178:5973-81
   PubMed Web of Science ®Google Scholar
• Wolk K, Haugen HS, Xu W, IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not. J Mol Med (Berl) 2009;87:523-36
   PubMed Web of Science ®Google Scholar
• Andoh A, Zhang Z, Inatomi O, Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 2005;129:969-84
   PubMed Web of Science ®Google Scholar
• Ikeuchi H, Kuroiwa T, Hiramatsu N, Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum 2005;52:1037-46
   PubMed Web of Science ®Google Scholar
• Aggarwal S, Xie MH, Maruoka M, Acinar cells of the pancreas are a target of interleukin-22. J Interferon Cytokine Res 2001;21:1047-53
   PubMed Web of Science ®Google Scholar
• Lubberts E. Th17 cytokines and arthritis. Semin Immunopathol 2010;32:43-53
   PubMed Web of Science ®Google Scholar
• Arend WP, Dayer JM. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum 1995;38:151-60
   PubMed Web of Science ®Google Scholar
• Hu Y, Li H, Zhang L, Elevated profiles of Th22 cells and correlations with Th17 cells in patients with immune thrombocytopenia. Hum Immunol 2012;73:629-35
   PubMed Web of Science ®Google Scholar
• Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell 1996;85:307-10
   PubMed Web of Science ®Google Scholar
• Abdollahi-Roodsaz S, Joosten LA, Koenders MI, Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest 2008;118:205-16
   PubMed Web of Science ®Google Scholar
• Shahrara S, Huang Q, Mandelin AM II, Pope RM. TH-17 cells in rheumatoid arthritis. Arthritis Res Ther 2008;10:R93
   PubMed Web of Science ®Google Scholar
• Nenci A, Becker C, Wullaert A, Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 2007;446:557-61
   PubMed Web of Science ®Google Scholar
• Cobrin GM, Abreu MT. Defects in mucosal immunity leading to Crohn's disease. Immunol Rev 2005;206:277-95
   PubMed Web of Science ®Google Scholar
• Schmechel S, Konrad A, Diegelmann J, Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status. Inflamm Bowel Dis 2008;14:204-12
   PubMed Web of Science ®Google Scholar
• Brand S, Beigel F, Olszak T, IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 2006;290:G827-38
   PubMed Web of Science ®Google Scholar
• Wehkamp J, Fellermann K, Herrlinger KR, Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease. Eur J Gastroenterol Hepatol 2002;14:745-52
   PubMed Web of Science ®Google Scholar
• Nagahama K, Ogawa A, Shirane K, Protein kinase C theta plays a fundamental role in different types of chronic colitis. Gastroenterology 2008;134:459-69
   PubMedGoogle Scholar
• Sugimoto K, Ogawa A, Mizoguchi E, IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 2008;118:534-44
   PubMed Web of Science ®Google Scholar
• Neufert C, Pickert G, Zheng Y, Activation of epithelial STAT3 regulates intestinal homeostasis. Cell Cycle 2010;9:652-5
   PubMed Web of Science ®Google Scholar
• Ouyang W. Distinct roles of IL-22 in human psoriasis and inflammatory bowel disease. Cytokine Growth Factor Rev 2010;21:435-41
   PubMed Web of Science ®Google Scholar
• Michalak-Stoma A, Pietrzak A, Szepietowski JC, Cytokine network in psoriasis revisited. Eur Cytokine Netw 2011;22:160-8
   PubMed Web of Science ®Google Scholar
• Hueber AJ, McInnes IB. Immune regulation in psoriasis and psoriatic arthritis–recent developments. Immunol Lett 2007;114:59-65
   PubMed Web of Science ®Google Scholar
• Nograles KE, Davidovici B, Krueger JG. New insights in the immunologic basis of psoriasis. Semin Cutan Med Surg 2010;29:3-9
   PubMed Web of Science ®Google Scholar
• Mak RK, Hundhausen C, Nestle FO. Progress in understanding the immunopathogenesis of psoriasis. Actas Dermosifiliogr 2009;100(Suppl 2):2-13
   PubMedGoogle Scholar
• Kagami S, Rizzo HL, Lee JJ, Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J Invest Dermatol 2010;130:1373-83
   PubMed Web of Science ®Google Scholar
• Boniface K, Guignouard E, Pedretti N, A role for T cell-derived interleukin 22 in psoriatic skin inflammation. Clin Exp Immunol 2007;150:407-15
   PubMed Web of Science ®Google Scholar
• Rongioletti F, Fiorucci C, Parodi A. Psoriasis induced or aggravated by drugs. J Rheumatol Suppl 2009;83:59-61
   PubMedGoogle Scholar
• Nickoloff BJ. Cracking the cytokine code in psoriasis. Nat Med 2007;13:242-4
   PubMed Web of Science ®Google Scholar
• Liang SC, Tan XY, Luxenberg DP, Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 2006;203:2271-9
   PubMed Web of Science ®Google Scholar
• Boniface K, Bernard FX, Garcia M, IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol 2005;174:3695-702
   PubMed Web of Science ®Google Scholar
• Volpe E, Touzot M, Servant N, Multiparametric analysis of cytokine-driven human Th17 differentiation reveals a differential regulation of IL-17 and IL-22 production. Blood 2009;114:3610-14
   Web of Science ®Google Scholar
• Ota Y, Saitoh Y, Suzuki S, Fibroblast growth factor 5 inhibits hair growth by blocking dermal papilla cell activation. Biochem Biophys Res Commun 2002;290:169-76
   PubMed Web of Science ®Google Scholar
• Cho YM, Woodard GL, Dunbar M, Hair-cycle-dependent expression of parathyroid hormone-related protein and its type I receptor: evidence for regulation at the anagen to catagen transition. J Invest Dermatol 2003;120:715-27
   Google Scholar
• Almus FE, Rao LV, Pendurthi UR, Mechanism for diminished tissue factor expression by endothelial cells cultured with heparin binding growth factor-1 and heparin. Blood 1991;77:1256-62
   Google Scholar
• Winkles JA, Friesel R, Burgess WH, Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor). Proc Natl Acad Sci USA 1987;84:7124-8
   PubMed Web of Science ®Google Scholar
• Reuss B, Dono R, Unsicker K. Functions of fibroblast growth factor (FGF)-2 and FGF-5 in astroglial differentiation and blood-brain barrier permeability: evidence from mouse mutants. J Neurosci 2003;23:6404-12
   PubMed Web of Science ®Google Scholar
• Kovacs D, Falchi M, Cardinali G, Immunohistochemical analysis of keratinocyte growth factor and fibroblast growth factor 10 expression in psoriasis. Exp Dermatol 2005;14:130-7
   PubMed Web of Science ®Google Scholar
• Sharpe RJ, Arndt KA, Bauer SI, Maione TE. Cyclosporine inhibits basic fibroblast growth factor-driven proliferation of human endothelial cells and keratinocytes. Arch Dermatol 1989;125:1359-62
   PubMedGoogle Scholar
• Honorati MC, Cattini L, Facchini A. IL-17, IL-1beta and TNF-alpha stimulate VEGF production by dedifferentiated chondrocytes. Osteoarthritis Cartilage 2004;12:683-91
   PubMed Web of Science ®Google Scholar
• Albanesi C, Scarponi C, Cavani A, Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes. J Invest Dermatol 2000;115:81-7
   PubMed Web of Science ®Google Scholar
• Toda M, Leung DY, Molet S, Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. J Allergy Clin Immunol 2003;111:875-81
   PubMed Web of Science ®Google Scholar
• Koga C, Kabashima K, Shiraishi N, Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol 2008;128:2625-30
   PubMed Web of Science ®Google Scholar
• Kim BE, Leung DY, Boguniewicz M, Howell MD. Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin Immunol 2008;126:332-7
   PubMed Web of Science ®Google Scholar
• Ramanathan M Jr, Spannhake EW, Lane AP. Chronic rhinosinusitis with nasal polyps is associated with decreased expression of mucosal interleukin 22 receptor. Laryngoscope 2007;117:1839-43
   PubMed Web of Science ®Google Scholar
• Pan HF, Ye DQ, Li XP. Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus. Nat Clin Pract Rheumatol 2008;4:352-3
   PubMedGoogle Scholar
• Deleuran B, Abraham DJ. Possible implication of the effector CD4+ T-cell subpopulation TH17 in the pathogenesis of systemic scleroderma. Nat Clin Pract Rheumatol 2007;3:682-3
   PubMedGoogle Scholar
• Ciprandi G, Fenoglio D, De Amici M, Serum IL-17 levels in patients with allergic rhinitis. J Allergy Clin Immunol 2008;122:650-1; e2
   Google Scholar
• Pan HF, Zhao XF, Yuan H, Decreased serum IL-22 levels in patients with systemic lupus erythematosus. Clin Chim Acta 2009;401:179-80
   PubMed Web of Science ®Google Scholar
• Cheng F, Guo Z, Xu H, Decreased plasma IL22 levels, but not increased IL17 and IL23 levels, correlate with disease activity in patients with systemic lupus erythematosus. Ann Rheum Dis 2009;68:604-6
   PubMed Web of Science ®Google Scholar
• Cao J, Chen C, Zeng L, Elevated plasma IL-22 levels correlated with Th1 and Th22 cells in patients with immune thrombocytopenia. Clin Immunol 2011;141:121-3
   Google Scholar
• Cao J, Chen C, Li L, Effects of high-dose dexamethasone on regulating interleukin-22 production and correcting Th1 and Th22 polarization in immune thrombocytopenia. J Clin Immunol 2012;32:523-9
   PubMed Web of Science ®Google Scholar
• Lavoie TN, Stewart CM, Berg KM, Expression of interleukin-22 in Sjogren's syndrome: significant correlation with disease parameters. Scand J Immunol 2011;74:377-82
   PubMed Web of Science ®Google Scholar
• Truchetet ME, Brembilla NC, Montanari E, Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease. Arthritis Res Ther 2011;13:R166
   PubMed Web of Science ®Google Scholar
• Singh B, Nikoopour E, Huszarik K, Immunomodulation and regeneration of islet Beta cells by cytokines in autoimmune type 1 diabetes. J Interferon Cytokine Res 2011;31:711-19
   Google Scholar
• Gurney AL. IL-22, a Th1 cytokine that targets the pancreas and select other peripheral tissues. Int Immunopharmacol 2004;4:669-77
   PubMed Web of Science ®Google Scholar
• Gross DJ, Weiss L, Reibstein I, Amelioration of diabetes in nonobese diabetic mice with advanced disease by linomide-induced immunoregulation combined with Reg protein treatment. Endocrinology 1998;139:2369-74
   PubMedGoogle Scholar
• Dungan KM, Buse JB, Ratner RE. Effects of therapy in type 1 and type 2 diabetes mellitus with a peptide derived from islet neogenesis associated protein (INGAP). Diabetes Metab Res Rev 2009;25:558-65
   PubMed Web of Science ®Google Scholar
• Radaeva S, Sun R, Pan HN, Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hematology (Am Soc Hematol Educ Program) 2004;39:1332-42
   Google Scholar
• Chang H, Hanawa H, Liu H, Hydrodynamic-based delivery of an interleukin-22-Ig fusion gene ameliorates experimental autoimmune myocarditis in rats. J Immunol 2006;177:3635-43
   PubMed Web of Science ®Google Scholar
• Zhao Y, Yang J, Gao YD, Guo W. Th17 immunity in patients with allergic asthma. Int Arch Allergy Immunol 2010;151:297-307
   PubMed Web of Science ®Google Scholar
• Schnyder B, Lima C, Schnyder-Candrian S. Interleukin-22 is a negative regulator of the allergic response. Cytokine 2010;50:220-7
   Google Scholar
• Witte E, Witte K, Warszawska K, Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection. Cytokine Growth Factor Rev 2010;21:365-79
   PubMed Web of Science ®Google Scholar
• Endam LM, Bosse Y, Filali-Mouhim A, Polymorphisms in the interleukin-22 receptor alpha-1 gene are associated with severe chronic rhinosinusitis. Otolaryngol Head Neck Surg 2009;140:741-7
   PubMed Web of Science ®Google Scholar
• Smith AJ, Humphries SE. Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev 2009;20:43-59
   PubMed Web of Science ®Google Scholar
• Aujla SJ, Chan YR, Zheng M, IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 2008;14:275-81
   PubMed Web of Science ®Google Scholar
• Qiao D, Yang BY, Li L, ESAT-6- and CFP-10-specific Th1, Th22 and Th17 cells in tuberculous pleurisy may contribute to the local immune response against mycobacterium tuberculosis. Scand J Immunol 2011;73(4):330-7
   Google Scholar
• Akaqawa KS. Recent advances in tuberculosis immunity. Kekkaku 2012;87(2):61-70
   Google Scholar
• Kim CJ, Nazli A, Rojas DL, A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis. Mucosal immunol 2012; doi:10.1038/mi.2012.72
   Google Scholar
• Radaeva S, Sun R, Pan HN, Interleukin 22(IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 2004;39:1332-42
   PubMed Web of Science ®Google Scholar
• Zenewicz LA, Yancopoulos GD, Valenzuela DM, Interleukin-22 but not interkeukin-17 provides protection to hepatoctytes during acute liver inflammation. Immunity 2007;27:647-59
   PubMed Web of Science ®Google Scholar
• Levillayer F, Mas M, Levi-Acobas F, Interleukin 22 is a candidate gene for Tmevp3, a locus controlling Theiler's virus-induced neurological diseases. Genetics 2007;176:1835-44
   Google Scholar
• De Luca A, Zelante T, D'Angelo C, IL-22 defines a novel immune pathway of antifungal resistance. Mucosal Immunol 2010;3:361-73
   PubMed Web of Science ®Google Scholar
• Conti HR, Shen F, Nayyar N, Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 2009;206:299-311
   PubMed Web of Science ®Google Scholar
• Kisand K, Boe Wolff AS, Podkrajsek KT, Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med 2010;207:299-308
   PubMed Web of Science ®Google Scholar
• Wilson MS, Feng CG, Barber DL, Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections. J Immunol 2010;184:4378-90
   Google Scholar
• Munoz M, Heimesaat MM, Danker K, Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. J Exp Med 2009;206:3047-59
   PubMed Web of Science ®Google Scholar
• Pitta MG, Romano A, Cabantous S, IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani. J Clin Invest 2009;119:2379-87
   Google Scholar
• Zhu A, Han H, Zhao H, Increased frequencies of Th17 and Th22 cells in the peripheral blood of patients with secondary syphilis. FEMS Immunol Med Microbial 2012; doi:10.1111/j.1574-695x.2012.01007.x
   Google Scholar
• Nagakawa H, Shimozato O, Yu L, Expression of interleukin-22 in murine carcinoma cells did not influence tumour growth in vivo but did improve survival of the inoculated hosts. Scand J Immunol 2004;60:449-54
   PubMed Web of Science ®Google Scholar
• Liu LM, Zhang XX, Zhang YM, The change of peripheral blood Th22 cells in patients with acute myeloid leukemia. China J Hematol 2012;33(2):133-5
   Google Scholar
• Bernardi RJ, Trump DL, Yu WD, Combination of 1alpha, 25-dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest ans apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling. Clin Cancer Res 2007;7:4164-73
   Google Scholar
• Romerio F, Zella D. MEK and ERK inhibitors enhance the anti-proliferative effect of interferon-alpha2b. FASEB J 2002;16:1680-2
   PubMed Web of Science ®Google Scholar
• Wu JJ, Zhang XD, Gillespie S, Selection for TRAIL resistance results in melanoma cells with high proliferative potential. EEBS Lett 2005;579:1940-4
   PubMedGoogle Scholar
• Fang JY, Richardson BC. The MAPK signaling pathways and colorectal cancer. Laucet Oncol 2005;6:322-7
   PubMed Web of Science ®Google Scholar
• Zhang W, Chen Y, Wei H, Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts. Clin Cancer Res 2008;14:6432-9
   PubMed Web of Science ®Google Scholar
• Ye ZJ, Zhou Q, Yin W, Interleukin 22-producing CD4+ T cells in malignant pleural effusion. Cancer Lett 2012;326:23-32
   PubMed Web of Science ®Google Scholar
• Zhuang Y, Peng LS, Zhao YL, Increased intratumoral IL-22-producing CD4+ T cells correlate with gastric cancer progrssion and predict poor patient survival. Cancer Immunol Immunother 2012; [Epub ahead of print]
   Google Scholar
• Liu T, Peng L, Yu P, Increased circulating Th22 and Th17 cells are associated with tumor progression and patient survival in Human Gastric Cancer. J Clin Immunol 2012; [Epub ahead of print]
   Google Scholar